Treatment for cocaine addiction
CA 2048609 A1 · Owner: The United States Of America, Represented By The Secretary, U.S. Departm Ent Of Commerce · Inventors: Weiss, Susan R. B.; Post, Robert M.; Aigner, Thomas G.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Toxic effects of cocaine can be blocked by chronic administration of carbamazepine in amount sufficient to achieve a 4-12 µg/ml blood concentration. In addition the dosing with carbamazepine, blocks the reinforcing effects of the cocaine thus decreasing, the likelihood of development of addiction to cocaine.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 1, 1990. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 1, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 1, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.